1 (626) 351-3700

Uncategorized

Brain Cancer Patients Display Appropriate Immune Responses and Decreasing Tumor Biomarkers in AIVITA Biomedical’s Phase 2 Clinical Trial

IRVINE, Calif., Oct. 24, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today updated data from its ongoing glioblastoma Phase 2 clinical trial investigating AIVITA’s platform immunotherapy targeting tumor-initiating cells. In approximately 80% of treated patients, sequential blood plasma biomarker analyses have identified the induction of a […]

Brain Cancer Patients Display Appropriate Immune Responses and Decreasing Tumor Biomarkers in AIVITA Biomedical’s Phase 2 Clinical Trial Read More »

AIVITA Biomedical Announces Publication Comparing Clinical Outcomes in Patients Treated with AIVITA’s Immunotherapy and Other Immunotherapies

New Comparison Indicates Superior Survival IRVINE, Calif., Oct. 17, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotechnology company specializing in innovative stem cell applications, announced the publication of an article titled “Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment“ in

AIVITA Biomedical Announces Publication Comparing Clinical Outcomes in Patients Treated with AIVITA’s Immunotherapy and Other Immunotherapies Read More »

AIVITA Biomedical Announces New Clinical Data in Ongoing Phase 2 Brain Cancer Trial

IRVINE, Calif., July 8, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today new clinical data from its ongoing glioblastoma Phase 2 clinical trial, investigating AIVITA’s platform immunotherapy targeting cancer stem cells. Blood plasma biomarker analyses have identified predictive markers of efficacy in seven of eight treated

AIVITA Biomedical Announces New Clinical Data in Ongoing Phase 2 Brain Cancer Trial Read More »

ClearFlow Announces Positive Randomized Controlled Trial Results and Inclusion in ERAS Guideline Recommendations

ANAHEIM, Calif.–(BUSINESS WIRE)– ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive clinical trial results of its PleuraFlow® device were presented at the American Association for Thoracic Surgery (AATS) 99th Annual meeting on May 4 in Toronto, Canada. This new data stems from a trial evaluating the use of ClearFlow’s PleuraFlow®Active Clearance Technology® (ACT®) System

ClearFlow Announces Positive Randomized Controlled Trial Results and Inclusion in ERAS Guideline Recommendations Read More »

AIVITA Biomedical Presents New Clinical Data at 2019 ASCO Annual Meeting

IRVINE, Calif., June 3, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that Chief Medical Officer Dr. Robert O. Dillman presented clinical data on melanoma patients treated with patient-specific vaccines on June 1 at the 55th Annual Meeting of ASCO in Chicago, Illinois. The data is being

AIVITA Biomedical Presents New Clinical Data at 2019 ASCO Annual Meeting Read More »

AIVITA Identifies Mechanism to Enhance Patient Response Rate to Next Generation Cancer Stem Cell Immunotherapy

AIVITA Identifies Mechanism to Enhance Patient Response Rate to Next Generation Cancer Stem Cell Immunotherapy   Findings suggest a combination with checkpoint inhibitors will enhance response rate beyond 72% survival, and facilitate a new Phase 1B approval   IRVINE, Calif., Feb. 12, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell

AIVITA Identifies Mechanism to Enhance Patient Response Rate to Next Generation Cancer Stem Cell Immunotherapy Read More »

The Hottest Enterprise Tech Startups to Watch in 2019

  #MariaDB momentum is heating up! @computerworlduk lists #MariaDB as one of the hottest enterprise tech startups in the world. http://ow.ly/I7fU30nAud5   Who are the hottest enterprise tech startups in the world? MariaDB as an open source database contender made the list by Computerworld UK. http://ow.ly/I7fU30nAud5   The hottest enterprise tech startups to watch in 2019  

The Hottest Enterprise Tech Startups to Watch in 2019 Read More »

Philips Recognized by Frost & Sullivan for Its Integrated Medication Adherence System, PMAS

Philips Recognized by Frost & Sullivan for Its Integrated Medication Adherence System, PMAS NEWS PROVIDED BY Frost & Sullivan  08:00 ET By connecting patients, pharmacists, caregivers, and providers, the PMAS delivers patient care in a decentralized format SANTA CLARA, Calif., Dec. 5, 2018 /PRNewswire/ — Based on its recent analysis of the North American medication adherence market, Frost

Philips Recognized by Frost & Sullivan for Its Integrated Medication Adherence System, PMAS Read More »

ROOT OF SKIN™ Skincare Line Sells Out at Product Launch on QVC Japan

ROOT OF SKIN™ Skincare Line Sells Out at Product Launch on QVC Japan IRVINE, Calif., Nov. 28, 2018 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that the Company’s revolutionary stem-cell based ROOT OF SKIN™ skincare line sold out at launch on the Japanese home shopping channel QVC Japan.

ROOT OF SKIN™ Skincare Line Sells Out at Product Launch on QVC Japan Read More »

AIVITA Biomedical Consumer Skincare Line ROOT OF SKIN™ to Be Sold on Home Shopping Channel QVC Japan

AIVITA Biomedical Consumer Skincare Line ROOT OF SKIN™ to Be Sold on Home Shopping Channel QVC Japan IRVINE, Calif., Oct. 30, 2018 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today it has executed a deal to sell the Company’s ROOT OF SKIN™ line of rejuvenating skincare products

AIVITA Biomedical Consumer Skincare Line ROOT OF SKIN™ to Be Sold on Home Shopping Channel QVC Japan Read More »

Scroll to Top